IMPORTANT
CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC:
GLUC)
Bentonville, AR -- November 3, 2022 -- InvestorsHub NewsWire --
Glucose Health, Inc. (OTC:
GLUC) ("Company") confirms the following important
corporate developments.
Three outstanding
candidates have now accepted nominations to serve as independent
directors of the Company. Charters for the enactment of Audit,
Compensation and Corporate Governance/Nominations committees, each
comprised, or majority comprised, of the independent directors,
have been established. The Company appointed a Public Company
Accounting Oversight Board (PCAOB) firm as auditor. Audit of fiscal
years 2020 and 2021, and interim reviews of the first two quarterly
periods of fiscal 2022, have been completed. A Certified Public
Accountant (CPA) with a decade of public company accounting and
audit preparatory experience has now agreed to be appointed to a
newly created officer position, Chief Accounting
Officer.
More updates for
shareholders and interested investors are forthcoming.
About Glucose Health, Inc. (OTC:
GLUC)
By specializing in producing healthy and delicious beverages
nutritionally appropriate1 for
the nation's 100+ million2 pre
and Type-2 diabetics, and additionally, with its planned launch of
a new healthy and delicious soluble fiber infused "ready-to-drink"
beverage, formulated to meet the nutritional needs of the 95% of
Americans who are considered fiber
deficient3,
Glucose Health, Inc. is uniquely positioned among all beverage
companies in America. Glucose Health, Inc. is a publicly traded
company with the ticker symbol OTC: GLUC.
For more GLUC news visit www.glucosehealthinc.com
Like us on Facebook at www.facebook.com/glucodown
1 For
citations visit www.glucodown.com/clinical-data
2 National
Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services
3
Closing America's Fiber Intake Gap.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124841
Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827
This news contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and while Glucose Health, Inc. is not subject
to the 1934 Securities and Exchange Act, contains forward-looking
statements within the meaning Section 21E of the Securities and
Exchange Act of 1934, as amended. Statements that are not a
description of historical facts constitute forward-looking
statements and may often, but not always, be identified by the use
of such words as "expects," "anticipates," "intends," "estimates,"
"plans," "potential, "possible," "probable, "believes," "seeks,"
"may, "will, "should," "could" or the negative of such terms or
other similar expressions. Actual results may differ materially
from those set forth in this release due to the risks and
uncertainties inherent in the Company's business. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.